Latest News

Adverse Events Associated With Antibody-Drug Conjugates Across Cancer Types

By

Andrea S. Blevins Primeau, PhD, MBA

Researchers say they have identified adverse events that are more likely to occur in cancer patients receiving antibody-drug conjugates.

Local Therapy Improves Overall Survival in cN1 Prostate Cancer

By

Andrea S. Blevins Primeau, PhD, MBA

Local therapy improves overall survival in patients with clinically lymph node-positive prostate cancer, a meta-analysis suggests.

Decrease in New Cancer Diagnoses Seen in 2020

There was a decrease in new cancer diagnoses, relative to expected numbers, between March 2020 and May 2020, according to a report.

Bariatric Surgery Linked to Lower Risk of Hematologic Cancer

Bariatric surgery is associated with a lower risk of hematologic cancer in women, a study suggests.

Diabetes Increases Risk of Upstaging in RCC

By

Natasha Persaud

Diabetes increases the likelihood of upstaging in patients with clinical T1 RCC undergoing partial or radical nephrectomy, a study suggests.

Study Evaluating Magrolimab in Patients With TP53-Mutant AML Discontinued

By

Diana Ernst, RPh

Gilead has discontinued the ENHANCE-2 study, which was designed to evaluate magrolimab in AML patients with TP53 mutations.

Survey: Most Cancer Patients Use Complementary or Alternative Medicine

By

Andrea S. Blevins Primeau, PhD, MBA

In a recent survey, 70% of cancer patients said they use complementary or alternative medicine as part of their cancer care.

Studies Reveal Rhabdomyosarcoma Patients Who Benefit From Radiotherapy

By

Leah Lawrence

Researchers say they have identified which patients with rhabdomyosarcoma are most likely to benefit from radiotherapy.

Good Oral Health Linked to Improved Survival in Head and Neck Cancer

Good oral health is associated with improved survival in patients with head and neck cancer, a study suggests.

Bosulif Approved for Pediatric Patients With Chronic Phase Ph+ CML

By

Brian Park, PharmD

The FDA has approved bosulif (bosutinib) for patients aged 1 year or older with chronic phase Ph+ CML.

US Adults May Be Hesitant to Receive Updated COVID-19 Vaccines

More than half of US adults surveyed said they “definitely” or “probably” won’t be vaccinated with one of the updated COVID-19 vaccines.

Clinical Trial: Atezolizumab Plus Trastuzumab Emtansine in HER2+ Breast Cancer

By

Cancer Therapy Advisor Staff

Researchers are evaluating the effects of adding atezolizumab to adjuvant treatment with trastuzumab emtansine in patients with HER2-positive breast cancer.

US Military Service May Impact Risk of Certain Cancers

By

Leah Lawrence

Researchers have found several differences in cancer rates between members of the US military and the general US population.

Genes Linked to Aggressive Prostate Cancer

By

Leah Lawrence

Researchers say they have identified genes that should be considered for gene panel testing in prostate cancer.

Alpelisib-Associated Hyperglycemia May Be More Common in Practice Than in Trials

By

Andrea S. Blevins Primeau, PhD, MBA

Patients with metastatic breast cancer who receive alpelisib in clinical practice have higher rates of hyperglycemia than patients who receive the drug in clinical trials, a new study suggests.

Adding Novel Agents to Durvalumab Improves Responses in NSCLC

Combining neoadjuvant durvalumab with other agents improves response rates in patients with resectable non-small cell lung cancer.

Increased Exposure to PFAS, Phenols, and Parabens Linked to Prior Cancer Diagnosis

Higher exposure to PFAS, phenols, and parabens is associated with previous cancer diagnosis in women but not men, a study suggests.

Pfizer Restarts Production Plant in North Carolina Following Tornado Damage in July

A Pfizer plant that makes drugs and hospital supplies has restarted production after a 10-week shutdown.

Clinical Trial: Dato-DXd With or Without Durvalumab in Stage I-III TNBC

By

Cancer Therapy Advisor Staff

Researchers are conducting a phase 3 trial to compare Dato-DXd, with or without durvalumab, to investigator’s choice of treatment in patients with TNBC.

State Policies May Prevent Cancer Patients From Using Telehealth

By

Andrea S. Blevins Primeau, PhD, MBA

Privately-insured cancer patients living in states with restrictive telehealth policies were less likely to use telehealth in 2020 and 2021, a study showed.